ABT – abbott laboratories (US:NASDAQ)

News

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [Yahoo! Finance]
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [TheStreet.com]
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
Abbott Laboratories (ABT) had its price target raised by Barclays PLC from $142.00 to $144.00. They now have an "overweight" rating on the stock.
Abbott Laboratories (ABT) had its price target lowered by The Goldman Sachs Group, Inc. from $140.00 to $121.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com